At meeting held on 26 April 2017
Sword & Shield Pharma announced that the Board of Directors at its meeting held on 26 April 2017, has proposed the Amalgamation in the nature of Merger of Praveg Communications ("the Transferor Company" or "PCL") with Sword & Shield Pharma ("the Transferee Company" or "SSPL" or "the Company"), under Sections 230 to 232 of the Companies Act, 2013 and other applicable laws including the provisions of the Companies Act, 1956 to the extent applicable with the appointed date i.e. 01 April 2016. The same is subject to the approval of the Shareholders, the National Company Law Tribunal, Ahmedabad (NCLT) and all the other regulatory approvals.Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)